The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy

Background: Epidermal growth factor receptor (EGFR) monoclonal antibodies (mAbs) combined with chemotherapy in patients with RAS (rat sarcoma viral oncogene homolog) wild-type metastatic colorectal cancer (mCRC) can alleviate and stabilize the disease, effectively prolong the progression-free surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuan, Meiqin, Wang, Zeng, Lv, Wangxia, Pan, Hongming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006990/
https://www.ncbi.nlm.nih.gov/pubmed/35433839
http://dx.doi.org/10.3389/fmolb.2022.870395

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006990/
https://www.ncbi.nlm.nih.gov/pubmed/35433839
http://dx.doi.org/10.3389/fmolb.2022.870395

Ejemplares similares